Kura Oncology, Inc.

KURA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$9.19+2.00%

2026-08-03

Financials

Valuation Metrics

Kura Oncology, Inc.'s Market Cap is $816M. At end of 2025 it was $915M. Ranked #2605 of 3,112 in US market (top 84%), #1095 of 1,445 on NASDAQ (top 76%), #203 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 75%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$816M	US#2,605/3,112 Sec#203/269
Revenue	$72M	US#2,836/3,112 Sec#142/269
Net Income	$-295M	US—/3,112 Sec—/269
Total Assets	$653M	US#2,639/3,112 Sec#131/269
Net Assets	$108M	US#2,871/3,112 Sec#226/269
Value
P/B	7.56x	US#2,460/3,112 Sec#182/269
P/S	11.39x	US#2,698/3,112 Sec#126/269
FCF Yield	-10.35%	US—/3,112 Sec—/269
Profitability
ROA	-45.14%	US#2,947/3,112 Sec#203/269
Op. Margin	-443.54%	US#2,894/3,112 Sec#160/269
Revenue Growth	29.47%	US#510/3,112 Sec#70/269
Financial Health
Debt Ratio	504.87%	US#2,382/3,112 Sec#234/269
Total Debt	$24M	US#2,669/3,112 Sec#173/269
FCF	$-84M	US#2,554/3,112 Sec#140/269
Cash	$39M	US#2,677/3,112 Sec#239/269
Current Ratio	6.15x	US#391/3,112 Sec#126/269
Performance
1Y Return	52.66%	US#831/3,112 Sec#128/269
1M Return	-17.21%	US#2,887/3,112 Sec#223/269
From 52W High	-26.42%	US#2,009/3,112 Sec#143/269
1Y MDD	-39.04%	US#1,905/3,112 Sec#139/269
Trading
Volume	1,128,993 shares	US#1,378/3,112 Sec#138/269
Trading Value	$10M	US#2,325/3,112 Sec#187/269
Per Share
EPS	$-3.16	US—/3,112 Sec—/269
BPS	$1.98	US#2,510/3,112 Sec#178/269